Rossari Biotech LimitedROSSARICorporate

Chemicals Latest results: Jun 2026 14 quarters of data

₹454.65

MCap ₹2,518 Cr · P/E 16.7

Rossari Biotech Limited — Stock analysis & AI research Rossari Biotech Limited — Multibagger AI analysis Rossari Biotech Limited — Seasonality — best & worst months Rossari Biotech Limited — Technical indicators & charts Rossari Biotech Limited — Technical setup — score, trend, support & resistance Rossari Biotech Limited — Live exchange announcements

📋 High Promoter Holding Stocks 📈 MACD Bullish Crossover 📈 SuperTrend Bullish Signal 📈 Multi-Timeframe Bearish Stocks 🏭 Chemicals sector

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹697 Cr

Sales · Jun 2026

+28.2% YoY

₹81 Cr

Operating Profit · Jun 2026

+18.8% YoY

11.6%

OPM % · Jun 2026

-7.2% YoY

₹35 Cr

Net Profit · Jun 2026

+4.5% YoY

₹6.34

EPS · Jun 2026

+4.4% YoY

📝 Rossari Biotech Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Rossari Biotech Limited reported revenue of ₹697 crore for the quarter ended June 2026 (Q1 FY27), up 28.2% from ₹544 crore in the same quarter last year, and up 1.8% sequentially over the March 2026 quarter.

Net profit rose 4.5% year-on-year to ₹35 crore, from ₹34 crore. Earnings per share (EPS) came in at ₹6.34.

Operating profit stood at ₹81 crore — an operating margin (OPM) of 11.6%, compared with 12.5% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Rossari Biotech Limited posted revenue of ₹2,396 crore, a growth of 15.2% over FY25, with a net profit of ₹149 crore (up 9.9% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹2,550 crore with a net profit of ₹151 crore.

Valuation snapshot

At the current price of ₹454.65, ROSSARI has a market capitalisation of ₹2,518 crore and a trailing P/E of about 16.7.

Within the Chemicals industry, it is the 25th-largest of the 79 companies we track by market value.

Shareholding pattern

As of Sep 2026, promoters held 68.14%, foreign institutional investors (FIIs) 1.84%, domestic institutional investors (DIIs) 14.19%, public shareholders 15.83% of Rossari Biotech Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

₹2,518 Cr

Current Price ?

₹454.6

P/E ?

16.69below ind

Industry P/E ?

24.60

P/B ?

1.89

P/S ?

0.99

P/FCF ?

-14.39

Enterprise Value ?

₹2,954 Cr

EV/EBITDA ?

9.90

PEG ?

1.39

Earnings Yield ?

7.2%

Dividend Yield ?

0.11%

Profitability & Returns

Sales (TTM) ?

₹2,550 Cr

OPM ?

11.7%

Profit after tax (TTM) ?

₹151 Cr

EPS (TTM) ?

₹27.24

ROCE ?

15.0%

ROE ?

11.3%

ROA ?

6.6%

Growth

Sales — latest qtr ?

₹697 Cr

PAT — latest qtr ?

₹35 Cr

YoY qtr sales growth ?

28.2%

YoY qtr profit growth ?

4.5%

Sales growth (3y) ?

13%

Sales growth (5y) ?

28%

Profit growth (3y) ?

12%

Profit growth (5y) ?

13%

Financial Health

Debt ?

₹436 Cr

Debt to Equity ?

0.33

Interest Coverage ?

7.3

Current Ratio ?

N/A

Ownership

Promoter holding ?

68.14%

Change in promoter holding ?

-0.04%

Pledged percentage ?

N/A

Market

Return 3 months ?

-14.5%

Return 6 months ?

-9.8%

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	YoY %	QoQ %
Sales	406	411	483	464	473	490	498	513	580	544	586	582	685	697	+28.2%	+1.8%
Operating Profit	55	58	64	64	64	65	66	65	69	68	72	69	77	81	+18.8%	+4.7%
Other Income	3	2	1	4	1	1	1	1	2	1	2	1	20	4	+203.7%	-81.8%
Interest	4	6	5	4	3	4	4	5	6	6	6	8	9	11	+91.6%	+22.0%
Depreciation	16	14	15	15	16	15	15	18	18	18	18	20	24	26	+44.3%	+6.7%
Profit Before Tax	37	39	45	48	46	47	48	42	48	46	50	43	64	48	+3.4%	-25.5%
Net Profit	29	29	33	34	34	35	35	32	34	34	37	33	46	35	+4.5%	-23.7%
EPS	5.25	5.30	5.97	6.23	6.18	6.32	6.39	5.73	6.22	6.07	6.66	5.92	8.30	6.34	+4.4%	-23.6%
OPM %	13.4%	14.1%	13.3%	13.7%	13.5%	13.3%	13.2%	12.6%	11.9%	12.5%	12.3%	11.8%	11.2%	11.6%	-7.2%	+3.6%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric	FY25	FY26	TTM	YoY %
Sales	₹2,081 Cr	₹2,396 Cr	₹2,550 Cr	+15.2%
Operating Profit	₹265 Cr	₹286 Cr	₹298 Cr	+8.0%
OPM %	12.72%	11.92%	11.71%	-6.3%
NPM %	6.53%	6.23%	5.92%	-4.6%
Other Income	₹5 Cr	₹24 Cr	₹27 Cr	+411.0%
Depreciation	₹67 Cr	₹79 Cr	₹87 Cr	+18.7%
Interest	₹18 Cr	₹28 Cr	₹34 Cr	+55.1%
EBIT	₹198 Cr	₹206 Cr	₹211 Cr	+4.4%
PBT	₹185 Cr	₹203 Cr	₹204 Cr	+9.2%
Tax	₹36 Cr	₹22 Cr	₹22 Cr	-37.5%
Net Profit	₹136 Cr	₹149 Cr	₹151 Cr	+9.9%
EPS	₹24.66	₹26.95	₹27.22	+9.3%
Material Cost	₹1,061 Cr	₹792 Cr	₹958 Cr	-25.3%
Employee Cost	₹97 Cr	₹78 Cr	₹84 Cr	-19.7%
Extraordinary Items	—	—	—	—

🏛️ Balance Sheet (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Equity Capital	11	11	11	11	+0.0%
Reserves	904	1,037	1,174	1,322	+12.6%
Borrowings	74	119	218	436	+100.0%
Other Liabilities	375	401	482	520	+7.9%
Total Liabilities	1,364	1,567	1,886	2,289	+21.4%
Fixed Assets	585	578	598	811	+35.6%
CWIP	16	47	140	173	+23.6%
Investments	51	63	84	35	-58.3%
Other Assets	712	880	1,063	1,269	+19.4%
Total Assets	1,364	1,567	1,886	2,289	+21.4%

💧 Cash Flow (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Cash from Operating Activity	152	43	137	65	-52.6%
Cash from Investing Activity	-181	-103	-183	-219	-19.7%
Cash from Financing Activity	61	16	65	186	+186.2%
Net Cash Flow	32	-44	19	32	+68.4%
Free Cash Flow	120	-83	-21	-175	-733.3%
CFO/OP	89%	39%	74%	47%	-36.5%

➗ Ratios (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Debtor Days	78	85	83	85	+2.4%
Inventory Days	59	80	90	88	-2.2%
Days Payable	56	62	73	71	-2.7%
Cash Conversion Cycle	80	103	101	103	+2.0%
Working Capital Days	49	70	69	55	-20.3%
ROCE %	18%	18%	16%	15%	-6.2%

👥 Shareholding (latest 6 periods)

Metric	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026	% Chg
Promoters	68.18%	68.18%	68.15%	68.15%	68.14%	68.14%	+0.0%
FIIs	3.48%	2.70%	2.32%	2.18%	2.02%	1.84%	-8.9%
DIIs	17.84%	18.18%	18.25%	18.21%	14.64%	14.19%	-3.1%
Public	10.50%	10.95%	11.25%	11.46%	15.20%	15.83%	+4.1%
No. of Shareholders	91,791	91,387	89,249	86,972	87,580	86,622	-1.1%

⚖️ Peer comparison

Industry: Chemicals · top 25 of 79 companies · full page →

#	Company	CMP	MCap (Cr)	P/E	Sales TTM	NP TTM	OPM%	NPM%	Sales YoY%	NP YoY%	Qtr Rev Δ%	Qtr NP Δ%
1	NAVINFLUOR Navin Fluorine	₹8,545.00	43,843	55.4	3,634	790	33.9%	21.7%	41.1%	130.1%	44.1%	107.7%
2	DEEPAKNTR Deepak Nitrite	₹1,596.00	21,768	27.8	8,575	784	15.5%	9.1%	-4.8%	-22.5%	36.4%	207.4%
3	DEEPAKFERT Deepak Fertilisers	₹1,323.00	16,718	17.0	12,103	985	16.7%	8.1%	12.0%	-21.8%	22.5%	101.0%
4	TATACHEM Tata Chemicals	₹615.00	15,668	—	15,120	-1,971	11.3%	-13.0%	-2.0%	-543.2%	14.4%	-81.0%
5	PCBL PCBL Chemical	₹331.50	13,043	43.3	6,596	298	13.4%	4.5%	-12.5%	-46.0%	17.0%	64.8%
6	JUBLINGREA Jubilant Ingrevia	₹647.25	10,208	33.3	4,651	308	13.4%	6.6%	5.1%	10.3%	25.3%	40.9%
7	ALKYLAMINE Alkyl Amines	₹1,818.60	9,301	41.3	1,658	225	20.6%	13.5%	-2.3%	-3.8%	30.1%	93.1%
8	CLEAN Clean Science	₹820.00	8,715	37.4	982	232	35.7%	23.6%	-2.5%	-13.7%	21.9%	-4.7%
9	GNFC Gujarat Narmada	₹539.75	7,931	7.6	8,410	1,037	14.8%	12.3%	-1.5%	35.3%	39.8%	275.9%
10	GALAXYSURF Galaxy Surfactants	₹2,156.30	7,887	21.6	5,752	353	10.4%	6.1%	24.3%	-50.0%	39.4%	108.7%
11	NEOGEN Neogen Chemicals	₹2,403.50	7,221	180.9	926	36	16.6%	3.8%	10.9%	-17.6%	34.0%	66.8%
12	BALAMINES Balaji Amines	₹2,215.00	7,177	35.3	1,523	211	21.4%	13.9%	2.0%	6.5%	27.2%	113.9%
13	FCL Fineotex Chemical	₹53.07	6,180	41.6	1,012	148	16.7%	14.6%	44.8%	14.5%	174.8%	92.6%
14	ACI Archean Chemical	₹470.90	5,814	61.0	1,123	95	20.3%	8.5%	7.8%	-37.0%	8.9%	-24.4%
15	GULFOILLUB Gulf Oil	₹1,057.20	5,235	13.9	4,367	371	12.6%	8.5%	11.7%	-3.4%	30.6%	27.0%
16	FOSECOIND Foseco India	₹6,846.50	5,186	64.7	618	77	17.5%	12.5%	12.2%	-1.9%	9.2%	8.9%
17	GUJALKALI Gujarat Alkalies	₹696.50	5,115	77.0	4,497	66	11.2%	1.5%	7.0%	96.3%	12.6%	499.0%
18	LXCHEM Laxmi Organic	₹178.50	4,961	40.2	3,117	123	8.2%	4.0%	-4.7%	-43.4%	44.1%	194.8%
19	VISHNU Vishnu Chemicals	₹724.90	4,880	32.6	1,694	150	15.5%	8.8%	11.1%	12.2%	24.9%	23.0%
20	YASHO Yasho Industries	₹4,028.70	4,857	84.9	939	57	19.5%	6.1%	24.0%	771.1%	54.9%	801.3%
21	EPIGRAL Epigral	₹1,084.00	4,677	17.3	2,626	271	22.2%	10.3%	-0.9%	-7.2%	16.3%	-37.9%
22	TATVA Tatva Chintan	₹1,867.60	4,369	85.0	556	51	19.3%	9.2%	32.6%	702.6%	42.8%	128.3%
23	GHCL GHCL	₹418.85	3,839	7.4	3,043	525	23.0%	17.3%	-3.7%	-23.5%	-2.7%	31.8%
24	PREMEXPLN Premier Explosives	₹685.10	3,685	110.0	349	34	6.8%	9.6%	-7.0%	60.5%	-27.8%	-80.2%
25	ROSSARI Rossari Biotech	₹431.70	2,391	15.9	2,550	151	11.7%	5.9%	15.2%	9.9%	28.2%	4.5%

❓ Frequently asked questions

What was Rossari Biotech Limited's revenue in Q1 FY27?

What was Rossari Biotech Limited's net profit in Q1 FY27?